LOXL2 and neoplasm: Tumor-secreted LOXL-2 has been described to activate stroma fibroblasts (to α-SMA + myofibroblasts) and vascular smooth muscle cells through the H2O2-mediated activation of FAK/SRC and ErbB2/Erk2 signaling [79, 80].